메뉴 건너뛰기




Volumn 81, Issue 10, 2010, Pages 1135-1140

Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: A randomised, double-blind crossover trial

Author keywords

[No Author keywords available]

Indexed keywords

DRONABINOL; PLACEBO; TETRAHYDROCANNABINOL;

EID: 77958147396     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.200642     Document Type: Article
Times cited : (91)

References (38)
  • 1
    • 4243660652 scopus 로고    scopus 로고
    • The spectrum of patient symptoms in ALS and symptom management
    • Heiman-Patterson TD, Rampal N, Brannagan, et al. The spectrum of patient symptoms in ALS and symptom management. Neurology 2000;56(8 Suppl 3):A199.
    • (2000) Neurology , vol.56 , Issue.8 SUPPL. 3
    • Heiman-Patterson, T.D.1    Rampal, N.2    Brannagan3
  • 3
    • 70249150025 scopus 로고    scopus 로고
    • Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease
    • Bedlack RS, Pastula DM, Hawes J, et al. Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease. Amyotroph Lateral Scler 2009;10:210-5.
    • (2009) Amyotroph Lateral Scler , vol.10 , pp. 210-215
    • Bedlack, R.S.1    Pastula, D.M.2    Hawes, J.3
  • 5
    • 7044254695 scopus 로고    scopus 로고
    • Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: A randomized trial
    • Brooks BR, Thisted RA, Appel SH, et al. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology 2004;63:1364-70.
    • (2004) Neurology , vol.63 , pp. 1364-1370
    • Brooks, B.R.1    Thisted, R.A.2    Appel, S.H.3
  • 6
    • 0035007860 scopus 로고    scopus 로고
    • A double-blind, placeho-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis
    • DOI 10.1080/146608201300079364
    • Desnuelle C, Dib M, Garrel C, et al. Double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group. Amyotroph Lateral Scler Other Motor Neuron Disord 2001;2:9-18. (Pubitemid 32472143)
    • (2001) Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders , vol.2 , Issue.1 , pp. 9-18
    • Desnuelle, C.1    Dib, M.2    Garrel, C.3    Favier, A.4
  • 7
    • 0029977337 scopus 로고    scopus 로고
    • Dose-ranging study of riluzole in amyotrophic lateral sclerosis
    • Lacomblez L, Bensimon G, Leigh PN, et al. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 1996;347:1425-31. (Pubitemid 26161204)
    • (1996) Lancet , vol.347 , Issue.9013 , pp. 1425-1431
    • Lacomblez, L.1    Bensimon, G.2    Leigh, P.N.3    Guillet, P.4    Meininger, V.5
  • 8
    • 10544254257 scopus 로고    scopus 로고
    • Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis
    • WALS Study Group. Western Amyotrophic Lateral Sclerosis Study Group
    • Miller RG, Moore D, Young LA, et al. Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study Group. Neurology 1996;47:1383-8.
    • (1996) Neurology , vol.47 , pp. 1383-1388
    • Miller, R.G.1    Moore, D.2    Young, L.A.3
  • 9
    • 0035836649 scopus 로고    scopus 로고
    • Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis
    • Miller RG, Moore DH, Gelinas DF, et al. Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology 2001;56:843-8.
    • (2001) Neurology , vol.56 , pp. 843-848
    • Miller, R.G.1    Moore, D.H.2    Gelinas, D.F.3
  • 12
    • 0037218316 scopus 로고    scopus 로고
    • Therapeutic potential of cannabinoids in CNS disease
    • DOI 10.2165/00023210-200317030-00004
    • Croxford JL. Therapeutic potential of cannabinoids in CNS disease. CNS Drugs 2003;17:179-202. (Pubitemid 36286534)
    • (2003) CNS Drugs , vol.17 , Issue.3 , pp. 179-202
    • Croxford, J.L.1
  • 13
    • 0027366473 scopus 로고
    • Muscle cramp as the result of impaired GABA function - An electrophysiological and pharmacological observation
    • DOI 10.1002/mus.880161113
    • Obi T, Mizoguchi K, Matsuoka H, et al. Muscle cramp as the result of impaired GABA function - an electrophysiological and pharmacological observation. Muscle Nerve 1993;16:1228-31. (Pubitemid 23304861)
    • (1993) Muscle and Nerve , vol.16 , Issue.11 , pp. 1228-1231
    • Obi, T.1    Mizoguchi, K.2    Matsuoka, H.3    Takatsu, M.4    Nishimura, Y.5
  • 14
    • 0028076338 scopus 로고
    • Motor neuron 'bistability.' A pathogenetic mechanism for cramps and myokymia
    • Baldissera F, Cavallari P, Dworzak F. Motor neuron 'bistability.' A pathogenetic mechanism for cramps and myokymia. Brain 1994;117:929-39.
    • (1994) Brain , vol.117 , pp. 929-939
    • Baldissera, F.1    Cavallari, P.2    Dworzak, F.3
  • 15
    • 34548750944 scopus 로고    scopus 로고
    • Reflex inhibition of normal cramp following electrical stimulation of the muscle tendon
    • Khan SI, Burne JA. Reflex inhibition of normal cramp following electrical stimulation of the muscle tendon. J Neurophysiol 2007;98:1102-7.
    • (2007) J Neurophysiol , vol.98 , pp. 1102-1107
    • Khan, S.I.1    Burne, J.A.2
  • 16
    • 0033679502 scopus 로고    scopus 로고
    • Afterdischarge activity in neuropathic patients with frequent muscle cramps
    • Parisi L, Serrao M, Rossi P, et al. Afterdischarge activity in neuropathic patients with frequent muscle cramps. Acta Neurol Scand 2000;102:359-62.
    • (2000) Acta Neurol Scand , vol.102 , pp. 359-362
    • Parisi, L.1    Serrao, M.2    Rossi, P.3
  • 17
    • 33745418427 scopus 로고    scopus 로고
    • Axonal excitability properties in amyotrophic lateral sclerosis
    • DOI 10.1016/j.clinph.2006.04.016, PII S1388245706001799
    • Vucic S, Kiernan MC. Axonal excitability properties in amyotrophic lateral sclerosis. Clin Neurophysiol 2006;117:1458-66. (Pubitemid 43947716)
    • (2006) Clinical Neurophysiology , vol.117 , Issue.7 , pp. 1458-1466
    • Vucic, S.1    Kiernan, M.C.2
  • 18
    • 34047276467 scopus 로고    scopus 로고
    • Endocannabinoids mediate muscarine-induced synaptic depression at the vertebrate neuromuscular junction
    • DOI 10.1111/j.1460-9568.2007.05422.x
    • Newman Z, Malik P, Wu TY, et al. Endocannabinoids mediate muscarine-induced synaptic depression at the vertebrate neuromuscular junction. Eur J Neurosci 2007;25:1619-30. (Pubitemid 46549999)
    • (2007) European Journal of Neuroscience , vol.25 , Issue.6 , pp. 1619-1630
    • Newman, Z.1    Malik, P.2    Wu, T.-Y.3    Ochoa, C.4    Watsa, N.5    Lindgren, C.6
  • 19
    • 39049161976 scopus 로고    scopus 로고
    • Altered presymptomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice: Implications for excitotoxicity
    • DOI 10.1111/j.1460-9568.2008.06041.x
    • Zhao P, Ignacio S, Beattie EC, et al. Altered presymptomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice: implications for excitotoxicity. Eur J Neurosc 2008;27:572-9. (Pubitemid 351246277)
    • (2008) European Journal of Neuroscience , vol.27 , Issue.3 , pp. 572-579
    • Zhao, P.1    Ignacio, S.2    Beattie, E.C.3    Abood, M.E.4
  • 21
    • 78249275162 scopus 로고    scopus 로고
    • Treatment of cramps in amyotrophic lateral sclerosis/motor neuron disease. (Protocol)
    • Weber M, Feinberg D. Treatment of cramps in amyotrophic lateral sclerosis/motor neuron disease. (Protocol). Cochrane Database Sys Rev 2003.
    • (2003) Cochrane Database Sys Rev
    • Weber, M.1    Feinberg, D.2
  • 24
    • 0028203293 scopus 로고
    • The sleep disorders questionnaire. I: Creation and multivariate structure of SDQ
    • Douglass AB, Bornstein R, Nino-Murcia G, et al. The sleep disorders questionnaire. I: Creation and multivariate structure of SDQ. Sleep 1994;17:160-7.
    • (1994) Sleep , vol.17 , pp. 160-167
    • Douglass, A.B.1    Bornstein, R.2    Nino-Murcia, G.3
  • 25
    • 26844561209 scopus 로고    scopus 로고
    • The Functional Assessment of Anorexia/Cachexia Therapy (FAACT) appetite scale in veteran cancer patients
    • Chang VT, Xia Q, Kasimis B. The functional assessment of anorexia/cachexia therapy (FAACT) appetite scale in veteran cancer patients. J Support Oncol 2005;3:377-82. (Pubitemid 41448264)
    • (2005) Journal of Supportive Oncology , vol.3 , Issue.5 , pp. 377-382
    • Chang, V.T.1    Xia, Q.2    Kasimis, B.3
  • 26
    • 0020527558 scopus 로고
    • The hospital anxiety and depression scale
    • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
    • (1983) Acta Psychiatr Scand , vol.67 , pp. 361-370
    • Zigmond, A.S.1    Snaith, R.P.2
  • 27
    • 25444530723 scopus 로고    scopus 로고
    • Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
    • DOI 10.1212/01.wnl.0000176753.45410.8b
    • Rog DJ, Nurmikko TJ, Friede T, et al. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 2005;65:812-9. (Pubitemid 41362120)
    • (2005) Neurology , vol.65 , Issue.6 , pp. 812-819
    • Rog, D.J.1    Nurmikko, T.J.2    Friede, T.3    Young, C.A.4
  • 29
    • 1842580669 scopus 로고    scopus 로고
    • The effect of cannabis on tremor in patients with multiple sclerosis
    • Fox P, Bain PG, Glickman S, et al. The effect of cannabis on tremor in patients with multiple sclerosis. Neurology 2004;62:1105-9. (Pubitemid 38456503)
    • (2004) Neurology , vol.62 , Issue.7 , pp. 1105-1109
    • Fox, P.1    Bain, P.G.2    Glickman, S.3    Carroll, C.4    Zajicek, J.5
  • 30
    • 0031692812 scopus 로고    scopus 로고
    • Urinary excretion half-life of 11-nor-9-carboxy-delta9- tetrahydrocannabinol in humans
    • Huestis MA, Cone EJ. Urinary excretion half-life of 11-nor-9-carboxy- delta9-tetrahydrocannabinol in humans. Ther Drug Monit 1998;20:570-6.
    • (1998) Ther Drug Monit , vol.20 , pp. 570-576
    • Huestis, M.A.1    Cone, E.J.2
  • 31
    • 0032820058 scopus 로고    scopus 로고
    • 9- tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users
    • Smith-Kielland A, Skuterud B, Morland J. Urinary excretion of 11-nor-9-carboxydelta9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users. J Anal Toxicol 1999;23:323-32. (Pubitemid 29418298)
    • (1999) Journal of Analytical Toxicology , vol.23 , Issue.5 , pp. 323-332
    • Smith-Kielland, A.1    Skuterud, B.2    Morland, J.3
  • 32
  • 33
    • 0035437865 scopus 로고    scopus 로고
    • Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity
    • van der Stelt M, Veldhuis WB, Bar PR, et al. Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity. J Neurosci 2001;21:6475-9.
    • (2001) J Neurosci , vol.21 , pp. 6475-6479
    • Van Der Stelt, M.1    Veldhuis, W.B.2    Bar, P.R.3
  • 35
    • 33947278309 scopus 로고    scopus 로고
    • The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset
    • Shoemaker JL, Seely KA, Reed RL, et al. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. J Neurochem 2007;101:87-98.
    • (2007) J Neurochem , vol.101 , pp. 87-98
    • Shoemaker, J.L.1    Seely, K.A.2    Reed, R.L.3
  • 37
    • 33645224970 scopus 로고    scopus 로고
    • COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord
    • Yiangou Y, Facer P, Durrenberger P, et al. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol 2006;6:12.
    • (2006) BMC Neurol , vol.6 , pp. 12
    • Yiangou, Y.1    Facer, P.2    Durrenberger, P.3
  • 38
    • 77952624283 scopus 로고    scopus 로고
    • Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis
    • Rossi S, De Chiara V, Musella A, et al. Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009;19:1-8.
    • (2009) Amyotroph Lateral Scler , vol.19 , pp. 1-8
    • Rossi, S.1    De Chiara, V.2    Musella, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.